🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research is being done to study the safety and feasibility of implanti...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2024-12-01
Trial ID
NCT05700461
Treatments Being Tested
This study will evaluate the safety of tobemstomig (RO7247669) in combinati...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2023-04-21
Trial ID
NCT05805501
Treatments Being Tested
With the advent of immunotherapy, standard first-line treatment for patient...
Status
Unknown
Location
Institut de Cancérologie de l'Ouest
Start Date
2021-06-07
Trial ID
NCT04764487
Treatments Being Tested
This phase III trial compares the effect of adding surgery to a standard of...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2021-03-08
Trial ID
NCT04510597
Treatments Being Tested
The ARON-1 Study is designed as an International Multicentric Retrospective...
Status
Recruiting
Location
Ospedale di Macerata, UOC Oncologia
Start Date
2022-03-10
Trial ID
NCT05287464
Treatments Being Tested
The purpose of this research study is to test the safety and effectiveness ...
Status
Active Not Recruiting
Location
University of Iowa Hospitals & Clinics
Start Date
2022-09-19
Trial ID
NCT05363631
Treatments Being Tested
Systemic therapy for renal cell carcinoma (RCC) relies on 2 classes of agen...
Status
Recruiting
Location
Medical University of Vienna
Start Date
2024-04-12
Trial ID
NCT06364631
Treatments Being Tested
Multicenter Phase II Study of Axitinib +/- Pembrolizumab in First Line Trea...
Status
Unknown
Location
Ico - Paul Papin
Start Date
2022-06-01
Trial ID
NCT05096390
Treatments Being Tested
This is a phase II trial to evaluate the efficacy and safety of immune chec...
Status
Recruiting
Location
Department of Genitourinary Oncology, Peking University Cancer Hospital & Institute
Start Date
2024-02-09
Trial ID
NCT06211114
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of pembrol...
Status
Completed
Location
Multiple Locations
Start Date
2016-09-16
Trial ID
NCT02853331
Treatments Being Tested